Monoclonal Antibodies in Nanosystems as a Strategy for Cancer Treatment-Reference-Cited by-同舟云学术

Monoclonal Antibodies in Nanosystems as a Strategy for Cancer Treatment

Published:2022-12-14 Issue: Volume: Page:115-176
ISSN:
Container-title:Cancer Nanotechnology
language:
Short-container-title:

Author:

de Freitas João Vito Barroso,Reis Alice Vitoria Frota,Silva Alan Denis Olivindo,de Sousa Ana Carolina Cruz,Martins Jéssica Roberta Pereira,Nogueira Karina Alexandre Barros,da Silva Moreira Thais,Petrilli Raquel,Eloy Josimar O.

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-17831-3_5

Reference179 articles.

1. Abbas, A. K., Pillai, S., & Lichtman, A. H. (2019). Imunologia: Celular e Molecular (9th ed.). Elsevier Ltd.

2. Acharya, S., Dilnawaz, F., & Sahoo, S. K. (2009). Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials, 30, 5737–5750.

3. Aldahhan, R., Almohazey, D., & Khan, F. A. (2021). Emerging trends in the application of gold nanoformulations in colon cancer diagnosis and treatment. Seminars in Cancer Biology.

4. Alibakhshi, A., Abarghooi Kahaki, F., Ahangarzadeh, S., Yaghoobi, H., Yarian, F., Arezumand, R., Ranjbari, J., Mokhtarzadeh, A., & De La Guardia, M. (2017). Targeted cancer therapy through antibody fragments-decorated nanomedicines. Journal of Controlled Release, 268, 323–334.

5. Amin, M., Pourshohod, A., Kheirollah, A., Afrakhteh, M., Gholami-Borujeni, F., Zeinali, M., & Jamalan, M. (2018). Specific delivery of idarubicin to HER2-positive breast cancerous cell line by trastuzumab-conjugated liposomes. The Journal of Drug Delivery Science and Technology, 47, 209–214.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing fab fragment‐conjugated surface plasmon resonance‐based biosensor for detection of SalmonellaEnteritidis;Journal of Molecular Recognition;2024-02-23

2. Will nanomedicine become a good solution for the cardiotoxicity of chemotherapy drugs?;Frontiers in Pharmacology;2023-05-04